Papers in Future Lipidology
Page 3 · newest first
- Lipids and the endothelium: an updateFuture Lipidology · 2006
- Complex genetics of monogenic familial hypercholesterolemiaFuture Lipidology · 2006
- Effect of niacin on lipoproteins and atherosclerosisFuture Lipidology · 2006
- Antagonism between Type 1 and Type 2 diabetes in unsaturated fatty acid biosynthesisFuture Lipidology · 2006
- Sphingolipids in atherosclerosis: a metabolic underpinning of vascular diseaseFuture Lipidology · 2006
- Intracellular lipid transport: structure–function relationships in fatty acid binding proteinsFuture Lipidology · 2006
- Lipid metabolism in Alzheimer’s and Parkinson’s diseaseFuture Lipidology · 2006
- New insights into the regulation of cellular cholesterol efflux and high-density lipoprotein metabolismFuture Lipidology · 2006
- Adiposopathy: why do adiposity and obesity cause metabolic disease?Future Lipidology · 2006
- Lipid-lowering therapy with statins in postmenopausal women: a few answered and many unanswered questionsFuture Lipidology · 2006
- Fibrinolysis and diabetic vascular disease: roles of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitorFuture Lipidology · 2006
- The ACTIVATE study: lessons for the future of atherosclerotic therapyFuture Lipidology · 2006
- Peroxisome proliferator-activated receptor-ã and lipodystrophyFuture Lipidology · 2006
- Cholesteryl ester transfer protein inhibitors: new strategies for raising high-density lipoprotein cholesterolFuture Lipidology · 2006
- Noninvasive preclinical assessment of CADFuture Lipidology · 2006
- Transport of fatty acids into adipocytesFuture Lipidology · 2006
- LDL-apheresis therapy: current therapeutic practice and potential future useFuture Lipidology · 2006
- HDL and endothelial function: from molecular mechanisms to clinical observationsFuture Lipidology · 2006
- Tracking the dietary cholesterol moleculeFuture Lipidology · 2006
- Future directions in reducing hepatic lipotoxicityFuture Lipidology · 2006
- Pathways for phosphatidylcholine biosynthesis: targets and strategies for antimalarial drugsFuture Lipidology · 2006
- Physiological ligands of PPARs in inflammation and lipid homeostasisFuture Lipidology · 2006
- Fasting-induced adipose factor/angiopoietin–like protein 4: a potential target for dyslipidemia?Socio-Environmental Systems Modeling · 2006
- Therapeutic modalities following low-density lipoprotein cholesterol goal attainmentFuture Lipidology · 2006
- Prominin–1 (CD133): from progenitor cells to human diseasesFuture Lipidology · 2006
- Cellular mechanisms of lipodystrophy induction by HIV protease inhibitorsFuture Lipidology · 2006
- Liver X receptors: new drug targets to treat Type 2 diabetes?Future Lipidology · 2006
- Modification of lipids by reactive oxygen and nitrogen species: the oxy-nitroxy-lipidome and its role in redox cell signalingFuture Lipidology · 2006
- Adipokines and the signaling role of adipose tissue in inflammation and obesityFuture Lipidology · 2006
- Lipin: a determinant of adiposity, insulin sensitivity and energy balanceFuture Lipidology · 2006
- Targeted bioavailability of drugs by triggered release from liposomesFuture Lipidology · 2006
- Effects of cardiac rehabilitation on lipoprotein abnormalities in patients with Type 2 diabetes mellitus and metabolic syndromeFuture Lipidology · 2006
- Lipid interactions with ion channelsFuture Lipidology · 2006
- Liposomal encapsulation enhances the activity of immunostimulatory oligonucleotidesFuture Lipidology · 2006
- HDL/apoA-I infusion for atherosclerosis management: an emerging therapeutic paradigmFuture Lipidology · 2006